All news posts from February 01, 2001 to February 28, 2001

Ford Motor Company, in an effort to put the Explorer / Firestone debacle behind it, is moving aggressively to settle many of the personal injury lawsuits filed against the company. Injuryboard.com has learned that Ford settled six such cases today. Such a settlement rate is almost unheard of and signals Ford's acknow

Recently, lawyers for Firestone and Ford asked Indianapolis federal Judge Sarah Evans Barker to dismiss nearly 80 proposed class action lawsuits against the companies. Judge Barker is in charge of over 200 Ford-Firestone cases relating to the nearly 6.5 million Firestone tires recalled in August 2000. Over 150 people

In September 2000 Firestone hired civil engineering professor Sanjay Govindjee to conduct a study into why so many Firestone Wilderness AT and ATX tires were failing. Such failures have lead to catastrophic accidents in which almost 200 people have died. Govindjee recently released his report in which he found no one

Today, CVS and its on-line pharmacy announced that it is pulling all cold and diet products that contain phenylpropanolamine or PPA. The FDA has found that PPA is associated with an increased occurrence of strokes in young women. The FDA also feels that PPA is not safe for men. CVS urges its customers to visit their

On October 19, 2000 an FDA advisory committee issued a warning about an ingredient contained in many popular over-the-counter and prescription cold and weight loss medicines. The committee said that phenylpropanolamine, also known as PPA, may be responsible for hundreds of strokes in otherwise healthy people under the

On October 19, 2000 an FDA advisory committee issued a warning about an ingredient contained in many popular over-the-counter and prescription cold and weight loss medicines. The committee said that phenylpropanolamine, also known as PPA, may be responsible for hundreds of strokes in otherwise healthy people under the

On November 6, the Food and Drug Administration issued a public health advisory alerting consumers to stop using over-the-counter (OTC) and prescription drug products containing phenylpropanolamine because this ingredient has been associated with an increased risk of hemorrhagic stroke (bleeding in the brain). Phenyl

On November 6, the Food and Drug Administration issued a public health advisory alerting consumers to stop using over-the-counter (OTC) and prescription drug products containing phenylpropanolamine because this ingredient has been associated with an increased risk of hemorrhagic stroke (bleeding in the brain). Phenyl

The Food and Drug Administration's scientific advisory committee determined that phenylpropanolamine (PPA) cannot be classified as safe, a classification critical to drugs' ability to be sold without a prescription - based upon their interpretation of a study called Phenylpropanolamine and Risk of Hemorrhagic Stroke: F

The Food and Drug Administration's scientific advisory committee determined that phenylpropanolamine (PPA) cannot be classified as safe, a classification critical to drugs' ability to be sold without a prescription - based upon their interpretation of a study called Phenylpropanolamine and Risk of Hemorrhagic Stroke: F

Many doctors are recommending that their patients avoid cold medications and appetite suppressants that contain phenylpropanolamine, more commonly known as PPA. "There are safer alternatives out there, so why take the risk?" asked Dr. Ray Woosley, chairman of the pharmacology department at Georgetown University Medica

Many doctors are recommending that their patients avoid cold medications and appetite suppressants that contain phenylpropanolamine, more commonly known as PPA. "There are safer alternatives out there, so why take the risk?" asked Dr. Ray Woosley, chairman of the pharmacology department at Georgetown University Medica

Pharmaceutical companies spend billions of dollars each year in an effort to find novel drug therapies and bring them to market before the competition does. While this massive financial effort has led to many great scientific breakthroughs, it has also depleted companies' funds for post-approval monitoring of these ne

Today, CVS and its on-line pharmacy announced that it is pulling all cold and diet products that contain phenylpropanolamine or PPA. The FDA has found that PPA is associated with an increased occurrence of strokes in young women. The FDA also feels that PPA is not safe for men. CVS urges its customers to visit their

Hip replacement patients like Rhonda Silva of California are frustrated and frightened by the prospect of undergoing further surgery on their ailing hips. Silva, who suffers from osteoporosis and received a Sulzer Orthopedic Hip Replacement in April of 2000, is facing new surgery after her original Sulzer Hip began fa

In mid-January 2001, the fourth of what are likely to be many defective product lawsuits was filed against Sulzer Orthopedics. The plaintiff, Kelly Hicks, alleges that the Sulzer Artificial Hip Replacement is unreasonably dangerous and has caused her extreme pain and inconvenience. Hicks, 42, is seeking $3 million fr